Prof. Reinhold Kreutz
Charité – Medical University Berlin, Germany
Current Position | Professor of Hypertension and Clinical Pharmacology, Director: Department of Clinical Pharmacology and Toxicology, Charité - Universitätsmedizin Berlin, Germany | |
Current research focus | Clinical pharmacology of cardiovascular drugs; clinical and experimental hypertension with a focus on genetics of hypertensive target organ damage; pharmacogenomics; drug therapy in the elderly; drug safety | |
Medical School | 1980-1987 | University of Mainz and Bonn, Germany |
Research and Clinical Training | 1987-2000 | Training in Internal Medicine (Focus on Hypertension and Kidney Disease) and Clinical Pharmacology in Cologne, Bonn, Heidelberg, Boston und Berlin |
Lecturer | 1999 | Internal Medicine, Medical Faculty, Freie Universität Berlin |
Assistant Professor | 2004 | Clinical Pharmacology, Charité-Universitätsmedizin Berlin |
Associate Professor | 2010 | Professor of Hypertension and Clinical Pharmacology, Charité-Universitätsmedizin Berlin |
Awards, Honors & Memberships (selected) | 1991-1992 | Educational grant of the Deutsche Forschungsgemeinschaft at the University of Heidelberg, Germany, and Harvard Medical School, Boston, USA |
1993-1996 | Postdoctoral Research Fellowship for physicians, Howard Hughes Medical Institute, Harvard Medical School, Boston, USA | |
1993 | Franz Volhard Award, German Society of Hypertension | |
1996 | Young Investigator Award, Dr. C & F. Demuth Foundation, International Society of Hypertension | |
1996 | Elected as International Scientific Fellow, High Blood Pressure Council, American Heart Association | |
1998 | Member of the Centre for Evidence-Based Medicine, Oxford, UK | |
2001 | Fellow der American Heart Association (FAHA) Member European Council for Blood Pressure & Cardiovascular Research (ECCR) |
|
2002 | European Hypertension Specialist of ESH® | |
2005 | Hypertension Specialist (DHL®) of the German Society of Hypertension | |
2010-2016 | Member managing board German Society of Hypertension | |
2011 | Head advisory committee for drug treatment of the German Society of Hypertension | |
2012 | Member Ethics Committee Federal State of Berlin | |
2015 | Member of the Scientific Council of the European Society of Hypertension (ESH) Elected as an associated member of the Drug Commission of the German Medical Association |
|
2016 | Member of the European Society of Cardiology (ESC) ESC Council on Stroke Member |
|
2017-2019 | Secretary of the Scientific Council of the European Society of Hypertension (ESH) | |
2018 | Fellow European Society of Cardiology (FESC) | |
2019-2021 | President of the European Society of Hypertension (ESH) |
Editorial Board Member: Journal of Hypertension, Journal of Clinical Hypertension, High Blood Pressure & Cardiovascular Prevention